Preclinical Imaging Evaluation of miRNAs’ Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review
Open Access
- 30 November 2021
- Vol. 13 (23), 6020
- https://doi.org/10.3390/cancers13236020
Abstract
Background: We have conducted a systematic review focusing on the advancements in preclinical molecular imaging to study the delivery and therapeutic efficacy of miRNAs in mouse models of breast cancer. Methods: A systematic review of English articles published in peer-reviewed journals using PubMed, EMBASE, BIOSIS™ and Scopus was performed. Search terms included breast cancer, mouse, mice, microRNA(s) and miRNA(s). Results: From a total of 2073 records, our final data extraction was from 114 manuscripts. The most frequently used murine genetic background was Balb/C (46.7%). The most frequently used model was the IV metastatic model (46.8%), which was obtained via intravenous injection (68.9%) in the tail vein. Bioluminescence was the most used frequently used tool (64%), and was used as a surrogate for tumor growth for efficacy treatment or for the evaluation of tumorigenicity in miRNA-transfected cells (29.9%); for tracking, evaluation of engraftment and for response to therapy in metastatic models (50.6%). Conclusions: This review provides a systematic and focused analysis of all the information available and related to the imaging protocols with which to test miRNA therapy in an in vivo mice model of breast cancer, and has the purpose of providing an important tool to suggest the best preclinical imaging protocol based on available evidence.Funding Information
- Progetti di Ricerca di Rilevante Interesse Nazionale (2017-grant 2017MHJJ55, MOLIMONCOBRAIN LAB)
This publication has 168 references indexed in Scilit:
- Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer CellsPLOS ONE, 2013
- Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast CancerOnline Journal of Public Health Informatics, 2011
- Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivotumor growthBreast Cancer Research, 2011
- Role of miR-10b in breast cancer metastasisBreast Cancer Research, 2010
- Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasisCancer and Metastasis Reviews, 2010
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery ApproachMolecular Therapy, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009